You have 9 free searches left this month | for more free features.

De novo Acute Myeloid Leukemia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myeloid Leukemia Trial in Taipei

Enrolling by invitation
  • Acute Myeloid Leukemia
    • Taipei, Taiwan
      National Taiwan University Hospital
    Aug 9, 2023

    Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Mitoxantrone hydrochloride liposome injection
    • +3 more
    • (no location specified)
    May 29, 2023

    Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Mitoxantrone hydrochloride liposome injection
    • +3 more
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jul 1, 2023

    Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • cladribine + homoharringtonine + cytarabine
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, Zhejiang University School of Med
    Jun 13, 2023

    Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

    Not yet recruiting
    • Acute Myeloid Leukemia
      • (no location specified)
      Sep 22, 2023

      Acute Myeloid Leukemia Trial in Baltimore, Houston (Atovaquone, Cytarabine, Daunorubicin)

      Active, not recruiting
      • Acute Myeloid Leukemia
      • Baltimore, Maryland
      • +1 more
      Oct 7, 2022

      Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

      Not yet recruiting
      • Acute Myeloid Leukemia in Children
      • Standard Intervention
      • Investigational Intervention
      • (no location specified)
      Aug 8, 2023

      Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

      Recruiting
      • Acute Biphenotypic Leukemia
      • +13 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 19, 2023

      Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

      Active, not recruiting
      • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
      • +9 more
      • Sewell, New Jersey
      • +4 more
      Dec 13, 2022

      MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

      Recruiting
      • Myelodysplastic Syndromes, de Novo
      • +10 more
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Jan 23, 2023

      Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

      Active, not recruiting
      • Adult Acute Lymphoblastic Leukemia in Remission
      • +14 more
      • radiation therapy
      • +8 more
      • Columbus, Ohio
        Arthur G. James Cancer Hospital and Solove Research Institute at
      Oct 7, 2022

      Novo Acute Myeloid Leukemia Trial in Spain (Mylotarg)

      Completed
      • Novo Acute Myeloid Leukemia
      • Badalona, Barcelona, Spain
      • +5 more
      Jan 26, 2021

      Leukemia, MDS, Childhood Acute Myeloid Leukemia in Remission Trial in Minneapolis (biological, drug, procedure)

      Recruiting
      • Leukemia
      • +12 more
      • filgrastim
      • +6 more
      • Minneapolis, Minnesota
        Masonic Cancer Center, University of Minnesota
      Jan 20, 2022

      Acute Myeloid Leukemia Trial in France (Cytarabine and Idarubicin, CPX-315)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Amiens, France
      • +29 more
      Apr 8, 2022

      Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

      Completed
      • Acute Myeloid Leukemia
      • +19 more
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +8 more
      • Lewes, Delaware
      • +16 more
      Aug 3, 2022

      PET Tracer Based FDG Signal for Predicting Prognosis in Acute

      Enrolling by invitation
      • Acute Myeloid Leukemia
      • No intervention
      • Guangzhou, Guangdong, China
        First Affiliated Hospital of Jinan University
      Jun 22, 2023

      Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56

      Not yet recruiting
      • Acute Myeloid Leukemia
      • bone marrow aspirate and biopsy
      • (no location specified)
      Aug 20, 2022

      Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

      Recruiting
      • Refractory/Relapse Acute Myeloid Leukemia
      • Kunming, Yunnan, China
        Department of Hematology,920th Hospital of Joint Logistic Suppor
      Mar 28, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

      Completed
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +23 more
      • Denver, Colorado
      • +2 more
      Jun 17, 2021

      Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Chicago (Laboratory Biomarker

      Completed
      • Acute Myeloid Leukemia
      • +4 more
      • Chicago, Illinois
        University of Chicago Comprehensive Cancer Center
      May 12, 2021

      Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

      Recruiting
      • Acute Myeloid Leukemia
      • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
      • "3+7"
      • Beijing, Beijing, China
        Chinese PLA General Hospital
      Sep 29, 2023

      Systemic Mastocytosis With AHNMD, Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Trial in Suzhou

      Not yet recruiting
      • Systemic Mastocytosis With AHNMD
      • Acute Myeloid Leukemia With T(8;21)(Q22;Q22)
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University, Jiangsu Ins
        Aug 16, 2022

        Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute

        Recruiting
        • Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
        • +9 more
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 27, 2021

        MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)

        Recruiting
        • Myelodysplastic Syndromes
        • +2 more
        • IFN-γ (interferon gamma-1b) injection
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Jan 5, 2023